🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Nucleotide reverse transcriptase inhibitors (NRTIs)

Found 31 matching trials

Human Immunodeficiency Virus (HIV) Postexposure Prophylaxis (PEP) With Darunavir/Ritonavir (DRV/r)

PHASE3

The primary purpose of this study is to assess the rate of early discontinu...

Status

Completed

Location

Multiple Locations

Start Date

2011-11-25

Trial ID

NCT01516970

Treatments Being Tested

Darunavir/Ritonavir (DRV/r)Lopinavir in fixed combination with Ritonavir Zidovudine NRTIs Efavirenz

Safety Of Nrtis for Alzheimer's Therapeutic Advancement in Singapore Study

PHASE1

Recent studies have identified an association between Alzheimer's Disease (...

Status

Active Not Recruiting

Location

National University Hospital

Start Date

2025-06-30

Trial ID

NCT07210528

Treatments Being Tested

Emtricitabine (FTC)Descovy® (TAF/FTC)Placebo to Match Emtricitabine 200mg/Tenofovir Alafenamide 25 mg.Placebo Capsules to Match Emtricitabine Capsules, 200mg.

Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters

N/A

The U.S. Department of Health and Human Services (HHS) guidelines recommend...

Status

Completed

Location

USC CRS

Start Date

2009-06

Trial ID

NCT00851799

Treatments Being Tested

Emtricitabine/tenofovir disoproxil fumarate Ritonavir Atazanavir Raltegravir Darunavir

Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children

PHASE2

Little is known about what treatment combinations are best for HIV infected...

Status

Completed

Location

Usc La Nichd Crs

Start Date

2002-08

Trial ID

NCT00039741

Treatments Being Tested

NRTIs (ABC, FTC, FTC/TDF, 3TC, 3TC/AZT, d4T, TDF, ddC, AZT)NNRTIs (EFV, NVP)PIs (AMP, IDV, LPV/r, NFV, SQV, RTV)

Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)

PHASE2

This is a single-group, open-label, multi-site study in pediatric participa...

Status

Recruiting

Location

University of Colorado at Denver ( Site 0108)

Start Date

2021-02-03

Trial ID

NCT04375800

Treatments Being Tested

Doravirine 2 NRTIs DOR/3TC/TDF

A Study With TMC125 in Human Immunodeficiency Virus (HIV) Type 1 Infected Patients, Who Were Treated With TMC125 Arm in a Sponsor-Selected TMC125 Study

PHASE2

The purpose of this study is to evaluate the long-term safety and tolerabil...

Status

Completed

Location

Multiple Locations

Start Date

2005-06

Trial ID

NCT00128830

Treatments Being Tested

Etravirine (ETR)Nucleotide reverse transcriptase inhibitors (NRTIs)Protease inhibitors (PIs)Enfuvirtide (ENF)

A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Activity of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 Years

PHASE2

The purpose of this study is to evaluate the pharmacokinetics, safety and a...

Status

Completed

Location

Multiple Locations

Start Date

2011-01

Trial ID

NCT00799864

Treatments Being Tested

Rilpivirine Zidovudine Abacavir Tenofovir disoproxil fumarate Lamivudine Emtricitabine

Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Administration When Coadministered With Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Antiretroviral-Experienced Human Immunodeficiency Virus Type 1 Infected Subjects

PHASE3

The purpose of this study was to compare the safety, tolerability, and anti...

Status

Completed

Location

Medical Information - Abbott (1-800-633-9110)

Start Date

2006-08

Trial ID

NCT00358917

Treatments Being Tested

lopinavir/ritonavir (LPV/r) tablet with nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs)lopinavir/ritonavir (LPV/r) tablet with nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs)

Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing Dolutegravir and Associated Nucleoside / Nucleotide Reverse Transcriptase Inhibitors Backbone

The main objective of the study is to characterize the diffusion of doluteg...

Status

Completed

Location

Antoine-Beclere Hospital

Start Date

2020-02-10

Trial ID

NCT04133012

Treatments Being Tested

Samplings

Safety and Efficacy of a Switch to Doravirine, Tenofovir, Lamivudine (MK-1439A) in Human Immunodeficiency Virus (HIV-1)-Infected Participants Virologically Suppressed on an Anti-retroviral Regimen in Combination With Two Nucleoside Reverse Transcriptase Inhibitors (MK-1439A-024)

PHASE3

The multicenter, open label, randomized study will evaluate the safety and ...

Status

Completed

Location

Multiple Locations

Start Date

2015-06-09

Trial ID

NCT02397096

Treatments Being Tested

Doravirine, Tenofovir, Lamivudine Baseline regimen of ritonavir- or cobicistat-boosted protease inhibitor Baseline regimen of cobicistat-boosted elvitegravir Baseline regimen of a non-nucleoside reverse transcriptase inhibitor Baseline regimen of two nucleoside reverse transcriptase inhibitors

Previous Next